BETA
Beta Drugs Limited
Pharmaceuticals · ₹1,417 Cr market cap
A pharmaceutical manufacturer specializing in oncology drugs, Beta Drugs Ltd produces a comprehensive range of anti-cancer medications serving patients across India and international markets. The company operates through both domestic and export channels, distributing its products to institutional buyers, hospitals, and retail segments within the healthcare sector. Its focused expertise in oncology therapeutics and manufacturing capabilities position it within the critical healthcare segment addressing cancer treatment needs across emerging and established markets worldwide.
2
Tracked investors holding
0
Tracked moves
₹2,190
Share price
Top investors holding Beta Drugs Limited
5.76%
1.68%